The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aortech.com

Stage

IPO | IPO

About AorTech Biomaterials

AorTech is the manufacturer of Elast-Eon, a biostable implantable silicone-urethane copolymer. The company is publicly listed in the UK on the Alternative Investment Market exchange (AIM:AOR) with dedicated sales and market development specialists in the US, and its 25,000 square foot ISO-Certified Technology and Biomaterials Manufacturing Center located in Melbourne, Australia. AorTech develops and manufactures medical-grade polyurethanes for use in medical devices and implants. The company's wholly-owned subsidiary, AorTech Biomaterials, based in Melbourne, Australia, was originally formed to commercialize materials developed by the Commonwealth Scientific and Industrial Research Organization. The company is now focused on these Elast-Eon materials, which have various applications, including in drug-eluting stents, in orthopedic devices (spinal discs) and reconstructive/cosmetic uses (breast implants). AorTech has sold its heart valve business.

AorTech Biomaterials Headquarter Location

Prestige Travel Suite, Barclays Bank House 81-83 Victoria Road

KT6 4NS,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • What is AorTech Biomaterials's latest funding round?

    AorTech Biomaterials's latest funding round is IPO.

  • Who are AorTech Biomaterials's competitors?

    Competitors of AorTech Biomaterials include Tepha, Noraker, Freedom Innovations, Amaranth Medical, Anteis and 12 more.

You May Also Like

B
BioControl

BioControl - New generation of active implantable devices affecting the behavior of muscles and nerves of the autonomic nervous system. The company sold its urology business for $90M to American Medical Systems.

Noraker Logo
Noraker

Design, manufacturing and marketing of long term implantable medical devices dedicated to bone reconstruction for applications in orthopedic, spinal, dental and skull-maxillo-facial surgeries.The company's main aim is to conceive bioresorbable implants helping surgeons to improve patients' welfare.

OrthAlign Logo
OrthAlign

OrthAlign provides orthopedic surgeons with user-friendly and cost-effect technology for precise alignment.

A
Artificial Airways

Artificial Airways is a Texas-based "C" corporation formed to commercialize a range of medical devices developed by Dr. Angel at the UT Health Science Center in San Antonio. Airtificial Airways' devices incorporate "stent" technologies to address critical needs in the performance of existing pulmonary and cardiovascular devices - unmet needs that result in frequent, expensive and life-threatening medical complications.

A
Astratech

Astra Tech develops and manufactures advanced healthcare devices and medical implants. The company aims to design products that improve the quality of life of those who use them, and to provide solutions that reduce the overall cost of care. Extensive experience, cross-disciplinary research and strictly controlled clinical trials are central to the company's business. In recent years, the company has invested heavily in integrating medical research with modern materials engineering, creating products with properties.

A
Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.